An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

被引:93
作者
Del Giudice, G
Hilbert, AK
Bugarini, R
Minutello, A
Popova, O
Toneatto, D
Schoendorf, I
Borkowski, A
Rappuoli, R
Podda, A
机构
[1] Chiron Vaccines, Res Ctr & Clin Res, I-53100 Siena, Italy
[2] Chiron Vaccines, Technol Dept & Clin Res, D-35041 Marburg, Germany
关键词
influenza; vaccine; adjuvant; heterovariant;
D O I
10.1016/j.vaccine.2006.01.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To test whether inactivated influenza vaccines distributed during the 2003-2004 influenza season in the northern hemisphere were able to confer protection against the mismatched variant A/Fujian/411/2002 virus strain, we measured haemagglutination inhibiting (H I) antibodies in elderly subjects vaccinated with three inactivated vaccines against the homologous A/H3N2 vaccine strain (A/Panama) and against the mismatched A/Fujian strain. The results showed that, while 76 to 80% of elder people vaccinated with conventional vaccines had protected levels of antibodies against the A/Fujian heterovariant strain, those vaccinated with the MF59-adjuvanted vaccine have protective levels of antibodies in > 98% of the cases. We conclude that MF59-adjuvanted vaccines confer protection also against influenza virus strains which are not fully matched with those included in the vaccine. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3063 / 3065
页数:3
相关论文
共 8 条
[1]  
[Anonymous], 2004, Wkly Epidemiol Rec, V79, P88
[2]   Vaccines - Shifting tactics in the battle against influenza [J].
Ault, A .
SCIENCE, 2004, 303 (5662) :1280-1280
[3]  
*CDC, 2004, MMWR-MORBID MORTAL W, V53, P8
[4]  
*CDC, MMWR, V52, P1286
[5]  
*CDC, 2004, MMWR-MORBID MORTAL W, V52, P1255
[6]   The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine [J].
Podda, A .
VACCINE, 2001, 19 (17-19) :2673-2680
[7]   DETERMINANTS OF IMMUNITY TO INFLUENZA INFECTION IN MAN [J].
POTTER, CW ;
OXFORD, JS .
BRITISH MEDICAL BULLETIN, 1979, 35 (01) :69-75
[8]   Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine: A potential priming strategy [J].
Stephenson, I ;
Bugarini, R ;
Nicholson, KG ;
Podda, A ;
Wood, JM ;
Zambon, MC ;
Katz, JM .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (08) :1210-1215